fbpx

Utilise pharmacists to improve health care in NSW

Wednesday, 22 January 2020

 

Implementation of four strategic measures would enable the state’s 8,811 registered pharmacists to help significantly improve health outcomes for the people of New South Wales, the Pharmaceutical Society of Australia has championed in its 2020-21 Pre-Budget Submission.

 

“During 2019, our state recorded the highest confirmed cases of influenza in Australia,” PSA NSW Branch President, Professor Peter Carroll said. “Children are particularly susceptible to the flu, yet studies suggest less than a third are being immunised each flu season.

 

“Parents can face hurdles to accessing a GP and getting their child vaccinated, so we must do more to increase uptake of this vital health intervention.
PSA recommends reducing the age of vaccination for influenza that trained pharmacists are able to administer to 10 years of age and over.

 

“Most Australians visit their pharmacist around 14 times a year” Professor Carroll explained. “This high level of accessibility, combined with the trust consumers have in the profession, will encourage more people to get immunised.

 

NSW has also experienced increases in notified cases of other diseases which can be prevented through immunisation. Last year the state had 55 cases of measles, compared to just 19 in 2018.

 

“Pharmacists are already authorised to provide vaccinations, but there are some limiting restrictions.

 

It is time to support pharmacists in the delivery of the full range of government funded vaccines other authorised immunisers can administer.

 

“Boosting vaccination rates and preventing outbreaks can ease pressure on our GP surgeries and hospital emergency departments.” Professor Carroll said.

 

Research released by the University of Technology Sydney in October 2019, found allowing community pharmacists to triage, manage and refer patients to doctors for common ailments like coughs and colds would create significant benefits for both patient health and the economy.

 

“More than 10 per cent of emergency department presentations in NSW are considered non-urgent,” Professor Carroll said. “Seventy percent of these presentations occur during the typical business hours of a community pharmacy.”

 

PSA recommends funding pharmacists for the management of non-urgent or low urgency medical conditions through community pharmacy. This should be supported by a co-ordinated health promotion that promotes visiting a community pharmacy instead of an emergency department for
non-urgent or low urgency medical conditions.

 

“Pharmacists have the skills and training to perform these functions safely and effectively. We estimate up to 331,233 thousand ED services in NSW are transferrable to community pharmacy, which would save the health system between $131m and $439m a year.”

 

PSA’s final proposed budget initiative aims to reduce preventable overdose deaths.

 

“Deaths from prescription medicines have outpaced deaths from illicit drugs,” Professor Carroll said. “There is no real time monitoring of prescription products in general practices and community pharmacies in NSW, therefore there is no way of identifying and helping those people who may be doctor shopping to obtain multiple prescriptions or require referral to support pathways.”

 

PSA is proposing the implementation of a mandatory Real Time Prescription Monitoring (RTPM) system for all drugs with the potential for addiction or misuse. It is also seeking funding of workforce training for community pharmacists to assist in the implementation of a RTPM system.

 

“NSW led the way in response to emergency supply of prescription medicines in the bushfire crisis, increasing access to these medicines to allow one month’s supply without a prescription,” Professor Carroll said. “We look forward to seeing NSW lead the way in other health initiatives that have a broader impact across the country.”

 

A full copy of the PSA 2021-21 NSW Budget Submission is available here

 

Media contact: PSA NSW State Manager, Simone Diamandis – (02) 9431 1100